Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Intellia Therapeutics, Inc

NTLA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
NTLA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NTLA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NTLA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in NTLA holdings by institutional investors

Quarterly net insider trading by NTLA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $30,000 Jan 19, 2022 Issue: Health Issues
  • $30,000 Oct 20, 2021 Issue: Health Issues
  • $30,000 Jul 18, 2021 Issue: Health Issues
  • $30,000 Apr 19, 2021 Issue: Health Issues
  • $50,000 Jan 20, 2021 Issue: Health Issues
  • $50,000 Oct 18, 2020 Issue: Health Issues
  • $50,000 Jul 19, 2020 Issue: Health Issues
  • $50,000 Apr 19, 2020 Issue: Health Issues
  • $50,000 Jan 20, 2020 Issue: Health Issues
  • $20,000 Oct 20, 2019 Issue: Health Issues
  • $15,000 Jul 01, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Apr 03, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Jan 15, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Jul 03, 2018 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Apr 17, 2018 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Jan 11, 2018 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Oct 28, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Jun 30, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Apr 14, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Jan 05, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Apr 07, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Jan 07, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $15,000 Oct 13, 2015 Issue: Health Issues Medical/Disease Research/Clinical Labs

Former government officials who have lobbied for NTLA

6 former government officials from 5 congressional offices at 1 lobbying firm have lobbied for NTLA, most recently Jul 18, 2021.

  • Steve Cohen
    Brittany Hernandez House New Senior Legislative Assistant, Legislative Assistant, Legislative Correspondent, Staff Assistant: Rep. Steve Cohen Formerly with Steve Cohen · CROSSROADS STRATEGIES, LLC · Jul 18, 2021
  • Patty Murray
    Shay Hancock Senate New Military Legislative Assistant, Sen. Patty Murray; Legislative Assistant, Rep. Adam Smith Formerly with Patty Murray · CROSSROADS STRATEGIES, LLC · Jul 19, 2020
  • Patty Murray
    Katherine Dapper Senate New Staff Assistant, Sen. Patty Murray Formerly with Patty Murray · CROSSROADS STRATEGIES, LLC · Sep 05, 2019
  • David Loebsack
    Marc Numedahl House New Legislative Director, Rep. Dave Loebsack; Military Legislative Assistant, Rep. Rick Larsen Formerly with David Loebsack · CROSSROADS STRATEGIES, LLC · Sep 05, 2019
  • Ed Whitfield
    Jason Van Pelt House New Legislative Director, Senior Legislative Asst, Legislative Asst, Staff Asst: Rep. Ed Whitfield Formerly with Ed Whitfield · CROSSROADS STRATEGIES, LLC · Sep 05, 2019
  • John P. Sarbanes
    Jason Gleason House New Chief of Staff/Legislative Director, Rep. John Sarbanes; Legislative Director/Legislative Asst/Legislative Correspondent/Staff Asst, Sen. Paul Sarbanes Formerly with John P. Sarbanes · CROSSROADS STRATEGIES, LLC · Sep 05, 2019

NTLA Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

NTLA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NTLA Income Statement
NTLA Balance Sheet
NTLA Cash Flow
U.S. Patents

New NTLA patent grants

  • Patent Title: Modified guide rnas Sep. 15, 2026
  • Patent Title: Compositions and methods comprising a ttr guide rna and a polynucleotide encoding an rna-guided dna binding agent Jul. 21, 2026
  • Patent Title: Compositions and methods for kallikrein (klkb1) gene editing Jul. 07, 2026
  • Patent Title: Compositions and methods for immunotherapy May. 19, 2026
  • Patent Title: Compositions and methods for kallikrein (klkb1) gene editing Nov. 25, 2025
  • Patent Title: Compositions and methods for treating alpha-1 antitrypsin deficiency Nov. 04, 2025
  • Patent Title: Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) Aug. 19, 2025
  • Patent Title: Compositions and methods for expressing factor ix Feb. 04, 2025
  • Patent Title: Modified guide rnas Dec. 24, 2024
  • Patent Title: Modified amine lipids Sep. 03, 2024
  • Patent Title: Compositions and methods for ttr gene editing and treating attr amyloidosis Apr. 23, 2024
  • Patent Title: Compositions and methods for ttr gene editing and treating attr amyloidosis Oct. 24, 2023
  • Patent Title: Polynucleotides, compositions, and methods for genome editing Jul. 11, 2023
  • Patent Title: Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) Jun. 13, 2023
  • Patent Title: Compositions and methods for treating alpha-1 antitrypsin deficiency Jan. 10, 2023
  • Patent Title: Modified guide rnas Oct. 25, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NTLA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NTLA News

Recent insights relating to NTLA

CNBC Recommendations

Recent picks made for NTLA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NTLA

NTLA Analyst Ratings

NTLA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NTLA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NTLA stock a Buy, Sell, or Hold?

  • What is the price target for $NTLA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NTLA Top Shareholders
Shareholder
Shares Held
NTLA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NTLA stock?

  • Who owns the most shares of $NTLA stock?

  • What funds own $NTLA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NTLA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NTLA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NTLA

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

  • Address Cambridge, MA
  • Market Cap 1.8 billion
  • Employees 377
  • Industrial Classification In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc (NTLA) Historical Stock Prices

Intellia Therapeutics, Inc (NTLA) closed at $12.69 on September 22, 2026. Over the past year its adjusted close ranged from $8.04 to $27.98. Daily prices go back to May 6, 2016, 2,609 trading days in all.

  • 1 month-1.17%
  • 3 months-16.79%
  • Year to date+41.16%
  • 1 year-26.48%
  • 3 years-60.82%
  • 5 years-91.83%
  • Max-42.58%
See every congressional and insider trade on the NTLA price chart

Quiver Premium charts NTLA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 12.27 12.97 12.14 12.69 12.69 3,921,412
Sep 21, 2026 12.50 12.65 12.14 12.22 12.22 3,738,743
Sep 18, 2026 12.15 12.47 11.87 12.14 12.14 8,626,304
Sep 17, 2026 11.99 12.87 11.95 12.26 12.26 5,760,971
Sep 16, 2026 11.46 11.75 11.37 11.49 11.49 4,590,886
Sep 15, 2026 11.75 11.82 11.24 11.36 11.36 3,990,812
Sep 14, 2026 11.64 12.11 11.64 11.87 11.87 2,598,787
Sep 11, 2026 12.10 12.19 11.69 11.74 11.74 2,713,508
Sep 10, 2026 11.90 11.96 11.66 11.93 11.93 3,924,870
Sep 9, 2026 12.50 12.82 12.19 12.21 12.21 4,934,631
Sep 8, 2026 12.83 12.89 12.43 12.74 12.74 4,130,293
Sep 4, 2026 12.59 12.96 12.52 12.74 12.74 2,796,288
Sep 3, 2026 12.86 12.92 12.40 12.68 12.68 3,004,964
Sep 2, 2026 12.67 13.13 12.28 12.76 12.76 3,245,595
Sep 1, 2026 12.52 12.81 12.34 12.69 12.69 2,184,155
Aug 31, 2026 12.64 12.85 12.44 12.73 12.73 2,925,419
Aug 28, 2026 13.11 13.49 12.68 12.87 12.87 3,441,960
Aug 27, 2026 13.26 13.45 13.00 13.11 13.11 2,453,164
Aug 26, 2026 13.38 13.50 12.98 13.19 13.19 2,707,210
Aug 25, 2026 12.84 13.73 12.76 13.51 13.51 4,091,924
Aug 24, 2026 12.60 12.79 12.24 12.56 12.56 3,117,690
Aug 21, 2026 12.65 13.13 12.65 12.84 12.84 3,347,693
Aug 20, 2026 12.95 13.04 12.29 12.44 12.44 4,703,599
Aug 19, 2026 12.10 13.35 12.01 13.28 13.28 6,114,892
Aug 18, 2026 11.80 12.10 11.44 11.60 11.60 3,178,625
Aug 17, 2026 11.91 12.22 11.75 12.09 12.09 1,818,943
Aug 14, 2026 11.83 12.04 11.41 11.91 11.91 2,360,909
Aug 13, 2026 12.11 12.17 11.81 11.83 11.83 2,945,751
Aug 12, 2026 12.06 12.31 11.88 12.09 12.09 2,041,977
Aug 11, 2026 11.96 12.14 11.69 12.02 12.02 2,569,330
Aug 10, 2026 11.80 12.24 11.75 12.02 12.02 3,032,375
Aug 7, 2026 11.88 12.08 11.47 11.94 11.94 4,937,181
Aug 6, 2026 10.64 11.32 10.64 11.24 11.24 4,341,322
Aug 5, 2026 11.31 11.43 10.85 10.97 10.97 4,734,413
Aug 4, 2026 10.97 11.34 10.76 11.32 11.32 4,339,794
Aug 3, 2026 10.55 10.84 10.40 10.77 10.77 3,319,884
Jul 31, 2026 11.13 11.19 10.60 10.68 10.68 2,650,733
Jul 30, 2026 10.91 11.13 10.83 11.09 11.09 3,183,984
Jul 29, 2026 10.77 11.18 10.54 10.80 10.80 3,489,846
Jul 28, 2026 10.52 10.94 10.15 10.89 10.89 4,859,991
Jul 27, 2026 10.99 11.31 10.63 10.67 10.67 2,892,763
Jul 24, 2026 11.26 11.32 10.71 10.73 10.73 3,462,561
Jul 23, 2026 10.96 11.35 10.92 11.10 11.10 3,768,746
Jul 22, 2026 11.25 11.46 11.07 11.13 11.13 2,378,876
Jul 21, 2026 11.06 11.56 10.93 11.47 11.47 3,518,645
Jul 20, 2026 11.52 11.66 10.91 10.92 10.92 3,740,865
Jul 17, 2026 11.73 11.84 11.35 11.38 11.38 4,329,237
Jul 16, 2026 12.43 12.59 11.65 11.86 11.86 6,531,741
Jul 15, 2026 13.13 13.38 12.88 13.04 13.04 4,026,082
Jul 14, 2026 13.31 13.57 13.00 13.30 13.30 4,053,636
Jul 13, 2026 13.76 13.77 12.77 13.02 13.02 7,479,067
Jul 10, 2026 15.44 15.44 14.10 14.21 14.21 6,175,425
Jul 9, 2026 16.59 17.16 15.14 15.44 15.44 7,387,669
Jul 8, 2026 16.81 17.09 16.35 16.84 16.84 3,547,444
Jul 7, 2026 17.85 18.11 16.85 17.43 17.43 3,171,882
Jul 6, 2026 17.33 18.08 16.17 17.84 17.84 3,845,751
Jul 2, 2026 17.63 18.48 17.30 17.56 17.56 4,165,309
Jul 1, 2026 16.78 17.83 16.72 17.24 17.24 3,730,828
Jun 30, 2026 16.58 16.95 16.00 16.92 16.92 3,801,554
Jun 29, 2026 16.67 17.18 15.94 16.61 16.61 5,581,610
Jun 26, 2026 15.75 16.96 15.67 16.68 16.68 9,823,554
Jun 25, 2026 15.62 16.26 15.57 16.03 16.03 3,472,852
Jun 24, 2026 15.33 16.12 15.30 15.50 15.50 3,621,475
Jun 23, 2026 15.43 15.93 15.06 15.25 15.25 4,883,994
Jun 22, 2026 15.87 16.32 15.57 15.75 15.75 5,103,712
Jun 18, 2026 15.53 16.20 15.04 15.67 15.67 8,849,172
Jun 17, 2026 14.87 16.73 14.43 15.20 15.20 12,427,239
Jun 16, 2026 14.78 14.92 13.54 14.55 14.55 8,657,706
Jun 15, 2026 12.78 15.00 12.76 14.92 14.92 16,409,533
Jun 12, 2026 12.29 12.99 11.95 12.11 12.11 10,223,429
Jun 11, 2026 12.15 12.45 11.81 12.35 12.35 7,935,809
Jun 10, 2026 12.66 13.14 12.19 12.20 12.20 3,961,341
Jun 9, 2026 13.77 14.25 12.54 12.89 12.89 5,627,605
Jun 8, 2026 13.83 14.04 13.32 13.49 13.49 3,420,275
Jun 5, 2026 14.50 14.79 12.89 13.54 13.54 7,484,259
Jun 4, 2026 13.20 15.49 13.12 14.75 14.75 9,609,094
Jun 3, 2026 12.97 13.04 12.47 13.02 13.02 3,101,443
Jun 2, 2026 13.48 13.55 12.88 13.13 13.13 3,945,312
Jun 1, 2026 13.76 14.17 13.41 13.73 13.73 3,569,484
May 29, 2026 13.70 14.30 13.12 14.07 14.07 5,540,219
May 28, 2026 13.47 13.99 13.20 13.68 13.68 4,531,666
May 27, 2026 12.60 13.75 12.51 13.44 13.44 6,548,661
May 26, 2026 12.67 12.89 12.24 12.61 12.61 3,623,185
May 22, 2026 12.40 12.89 12.35 12.60 12.60 3,198,831
May 21, 2026 11.96 12.46 11.82 12.37 12.37 4,440,053
May 20, 2026 11.91 12.53 11.79 12.26 12.26 4,905,711
May 19, 2026 12.27 12.42 11.84 11.94 11.94 5,520,815
May 18, 2026 13.78 13.88 12.11 12.69 12.69 9,646,283
May 15, 2026 13.35 14.14 13.24 13.67 13.67 14,834,401
May 14, 2026 14.16 14.38 12.91 13.09 13.09 14,169,622
May 13, 2026 13.97 14.58 13.75 14.28 14.28 3,757,903
May 12, 2026 14.34 14.50 13.52 13.99 13.99 4,658,012
May 11, 2026 14.06 15.55 13.97 14.42 14.42 7,237,854
May 8, 2026 14.07 14.55 13.73 14.09 14.09 5,804,319
May 7, 2026 13.78 14.06 13.41 13.71 13.71 4,043,553
May 6, 2026 13.24 13.88 13.11 13.85 13.85 3,808,533
May 5, 2026 14.15 14.33 13.20 13.31 13.31 4,882,345
May 4, 2026 13.31 14.07 13.31 13.87 13.87 6,481,855
May 1, 2026 13.39 13.54 12.80 13.26 13.26 5,801,000
Apr 30, 2026 12.62 14.06 12.62 13.48 13.48 13,108,674
Apr 29, 2026 12.14 12.95 11.76 12.45 12.45 26,793,595
Apr 28, 2026 12.82 14.16 12.72 13.20 13.20 15,164,250
Apr 27, 2026 14.23 14.75 12.39 13.04 13.04 27,514,980
Apr 24, 2026 15.89 16.04 13.42 13.63 13.63 9,028,426
Apr 23, 2026 16.80 16.97 15.56 15.87 15.87 5,493,787
Apr 22, 2026 15.71 16.58 15.65 16.57 16.57 3,762,650
Apr 21, 2026 15.45 15.91 15.22 15.31 15.31 4,311,094
Apr 20, 2026 14.75 15.30 14.53 15.21 15.21 2,670,692
Apr 17, 2026 14.58 15.14 14.49 14.95 14.95 3,094,742
Apr 16, 2026 14.95 14.97 13.88 14.16 14.16 3,609,670
Apr 15, 2026 14.88 15.28 14.46 14.94 14.94 2,708,785
Apr 14, 2026 14.42 15.15 14.35 14.78 14.78 2,989,897
Apr 13, 2026 13.30 14.47 13.30 14.26 14.26 3,298,300
Apr 10, 2026 13.87 13.89 13.28 13.49 13.49 1,809,407
Apr 9, 2026 13.73 13.98 13.62 13.83 13.83 1,427,254
Apr 8, 2026 14.11 14.49 13.57 13.87 13.87 3,015,570
Apr 7, 2026 13.20 13.56 12.85 13.55 13.55 2,344,076
Apr 6, 2026 13.17 13.72 13.17 13.30 13.30 1,943,374
Apr 2, 2026 12.69 13.27 12.47 13.13 13.13 2,750,476
Apr 1, 2026 12.95 13.65 12.95 13.27 13.27 3,026,846
Mar 31, 2026 11.87 12.99 11.87 12.82 12.82 4,201,751
Mar 30, 2026 12.36 12.36 11.62 11.65 11.65 3,620,680
Mar 27, 2026 13.12 13.16 12.12 12.37 12.37 3,736,304
Mar 26, 2026 13.02 14.02 12.82 13.24 13.24 5,712,787
Mar 25, 2026 13.11 13.67 13.03 13.26 13.26 3,006,142
Mar 24, 2026 12.95 13.18 12.63 12.81 12.81 3,534,494
Mar 23, 2026 12.93 13.34 12.66 13.11 13.11 3,107,048
Mar 20, 2026 13.13 13.58 12.80 12.84 12.84 5,219,356
Mar 19, 2026 12.91 13.46 12.66 13.15 13.15 2,742,696
Mar 18, 2026 13.20 13.65 13.14 13.21 13.21 2,698,414
Mar 17, 2026 13.38 13.66 13.38 13.48 13.48 2,228,730
Mar 16, 2026 13.05 13.65 12.88 13.38 13.38 3,707,821
Mar 13, 2026 13.02 13.32 12.55 12.76 12.76 2,853,878
Mar 12, 2026 12.88 13.07 12.56 12.85 12.85 3,282,959
Mar 11, 2026 13.34 13.40 12.83 13.01 13.01 3,074,019
Mar 10, 2026 13.64 14.15 13.35 13.47 13.47 2,828,148
Mar 9, 2026 13.25 14.14 13.07 13.89 13.89 4,025,671
Mar 6, 2026 12.73 13.54 12.55 13.44 13.44 3,322,915
Mar 5, 2026 13.63 14.12 12.98 13.15 13.15 4,294,296
Mar 4, 2026 13.98 14.12 13.41 13.82 13.82 5,896,498
Mar 3, 2026 14.79 14.79 13.60 13.61 13.61 8,311,471
Mar 2, 2026 13.79 15.51 12.75 15.44 15.44 14,441,871
Feb 27, 2026 13.84 14.29 13.57 13.78 13.78 3,245,402
Feb 26, 2026 14.09 14.30 12.70 14.28 14.28 4,901,626
Feb 25, 2026 13.60 13.93 13.41 13.42 13.42 2,284,798
Feb 24, 2026 13.46 13.84 13.12 13.58 13.58 2,845,519
Feb 23, 2026 12.51 13.19 12.40 13.16 13.16 2,335,441
Feb 20, 2026 12.79 12.96 12.51 12.64 12.64 2,522,820
Feb 19, 2026 12.21 13.08 12.10 13.04 13.04 2,042,215
Feb 18, 2026 12.08 12.70 12.00 12.48 12.48 2,517,846
Feb 17, 2026 11.82 12.47 11.66 12.22 12.22 2,381,507
Feb 13, 2026 11.54 12.32 11.54 11.87 11.87 2,630,058
Feb 12, 2026 11.88 11.95 11.21 11.62 11.62 2,945,870
Feb 11, 2026 11.89 12.04 11.36 12.00 12.00 3,590,637
Feb 10, 2026 12.32 12.54 11.75 11.91 11.91 2,999,350
Feb 9, 2026 12.00 12.49 11.76 12.49 12.49 4,010,140
Feb 6, 2026 11.32 12.33 11.32 12.28 12.28 4,612,997
Feb 5, 2026 11.98 12.20 10.94 11.09 11.09 5,866,487
Feb 4, 2026 13.03 13.07 11.96 12.36 12.36 4,978,146
Feb 3, 2026 13.14 13.76 12.51 13.05 13.05 3,617,048
Feb 2, 2026 12.99 13.41 12.80 13.06 13.06 3,206,052
Jan 30, 2026 13.46 13.97 12.94 13.15 13.15 5,299,530
Jan 29, 2026 13.86 14.67 13.67 13.90 13.90 4,817,543
Jan 28, 2026 14.97 15.00 13.59 13.82 13.82 6,208,693
Jan 27, 2026 16.51 17.09 14.20 14.83 14.83 15,000,384
Jan 26, 2026 14.38 14.70 13.86 13.95 13.95 6,420,979
Jan 23, 2026 15.81 15.95 14.50 14.63 14.63 8,085,121
Jan 22, 2026 14.03 15.94 13.76 15.90 15.90 10,546,205
Jan 21, 2026 12.98 14.49 12.94 14.03 14.03 9,241,364
Jan 20, 2026 12.10 13.17 11.93 12.83 12.83 9,586,621
Jan 16, 2026 11.88 12.75 11.70 12.50 12.50 5,749,553
Jan 15, 2026 11.99 12.35 11.34 11.87 11.87 5,441,045
Jan 14, 2026 11.75 12.34 11.66 12.02 12.02 5,495,509
Jan 13, 2026 11.61 12.29 11.20 11.74 11.74 7,926,009
Jan 12, 2026 10.41 11.45 10.14 11.43 11.43 6,747,714
Jan 9, 2026 10.98 10.98 10.13 10.38 10.38 6,868,261
Jan 8, 2026 10.72 10.74 10.32 10.52 10.52 6,732,492
Jan 7, 2026 9.84 10.58 9.77 10.13 10.13 5,085,858
Jan 6, 2026 9.37 10.17 9.31 9.73 9.73 4,307,364
Jan 5, 2026 9.21 9.70 9.13 9.37 9.37 5,783,651
Jan 2, 2026 9.23 9.36 9.05 9.21 9.21 2,736,215
Dec 31, 2025 9.06 9.13 8.94 8.99 8.99 3,020,988
Dec 30, 2025 9.17 9.25 8.99 9.06 9.06 2,191,326
Dec 29, 2025 9.34 9.36 8.98 9.14 9.14 4,004,588
Dec 26, 2025 9.57 9.57 9.16 9.44 9.44 1,839,871
Dec 24, 2025 9.46 9.62 9.26 9.59 9.59 1,450,650
Dec 23, 2025 9.50 9.56 9.34 9.42 9.42 2,580,550
Dec 22, 2025 9.20 9.85 9.19 9.70 9.70 2,883,444
Dec 19, 2025 8.90 9.54 8.90 9.23 9.23 6,588,767
Dec 18, 2025 8.94 9.16 8.74 8.88 8.88 3,357,150
Dec 17, 2025 9.13 9.55 8.78 8.79 8.79 3,282,273
Dec 16, 2025 9.00 9.26 8.91 9.12 9.12 2,499,992
Dec 15, 2025 9.08 9.22 8.90 9.14 9.14 3,952,149
Dec 12, 2025 9.61 9.68 9.02 9.02 9.02 3,405,589
Dec 11, 2025 9.33 9.67 9.25 9.55 9.55 3,067,838
Dec 10, 2025 9.27 9.70 9.15 9.37 9.37 2,754,028
Dec 9, 2025 9.36 9.60 9.22 9.30 9.30 3,141,806
Dec 8, 2025 9.89 9.95 9.35 9.44 9.44 3,465,086
Dec 5, 2025 9.59 9.66 9.36 9.61 9.61 4,030,451
Dec 4, 2025 8.91 9.91 8.85 9.74 9.74 5,915,559
Dec 3, 2025 8.23 9.12 8.13 9.06 9.06 4,745,086
Dec 2, 2025 8.43 8.49 8.09 8.10 8.10 4,317,292
Dec 1, 2025 8.81 8.89 8.39 8.42 8.42 4,532,914
Nov 28, 2025 8.62 9.10 8.53 8.99 8.99 3,707,792
Nov 26, 2025 8.63 8.63 8.40 8.52 8.52 3,141,304
Nov 25, 2025 8.39 8.61 8.18 8.55 8.55 4,110,944
Nov 24, 2025 8.26 8.37 8.13 8.35 8.35 3,962,841
Nov 21, 2025 8.15 8.43 7.95 8.21 8.21 6,252,317
Nov 20, 2025 8.50 8.88 7.95 8.04 8.04 6,196,531
Nov 19, 2025 8.53 8.63 8.20 8.24 8.24 4,012,256
Nov 18, 2025 8.45 8.63 8.22 8.47 8.47 5,588,904
Nov 17, 2025 8.55 8.80 8.23 8.48 8.48 6,091,083
Nov 14, 2025 8.49 8.88 8.38 8.70 8.70 6,865,090
Nov 13, 2025 9.36 9.62 8.56 8.67 8.67 9,573,207
Nov 12, 2025 10.02 10.33 9.28 9.49 9.49 7,177,228
Nov 11, 2025 9.59 10.26 9.38 10.18 10.18 6,971,387
Nov 10, 2025 10.71 10.77 9.65 9.73 9.73 13,521,275
Nov 7, 2025 9.14 10.11 8.96 9.52 9.52 25,413,219
Nov 6, 2025 13.50 13.51 12.22 12.32 12.32 8,932,176
Nov 5, 2025 12.45 13.69 12.15 13.57 13.57 6,499,940
Nov 4, 2025 12.60 13.11 12.19 12.20 12.20 5,743,233
Nov 3, 2025 13.12 13.60 12.20 13.07 13.07 8,783,061
Oct 31, 2025 12.55 13.38 12.13 12.62 12.62 14,229,328
Oct 30, 2025 11.78 12.70 11.63 12.27 12.27 12,677,079
Oct 29, 2025 13.77 14.00 12.62 13.12 13.12 18,010,674
Oct 28, 2025 14.78 14.79 13.72 13.96 13.96 17,527,917
Oct 27, 2025 13.73 16.76 13.21 14.79 14.79 52,534,651
Oct 24, 2025 26.11 26.35 25.30 25.60 25.60 2,977,112
Oct 23, 2025 24.59 25.95 24.27 25.89 25.89 2,782,231
Oct 22, 2025 26.69 26.90 24.14 24.58 24.58 6,200,211
Oct 21, 2025 27.60 27.86 26.70 26.97 26.97 5,140,008
Oct 20, 2025 25.56 28.25 25.50 27.98 27.98 7,554,957
Oct 17, 2025 24.31 25.18 23.99 24.75 24.75 3,835,359
Oct 16, 2025 25.93 26.82 24.65 24.91 24.91 4,936,846
Oct 15, 2025 24.48 26.32 24.23 25.93 25.93 5,517,692
Oct 14, 2025 23.10 24.83 21.89 23.90 23.90 4,957,527
Oct 13, 2025 24.88 25.81 23.42 23.76 23.76 6,972,152
Oct 10, 2025 25.62 25.78 23.22 24.52 24.52 8,648,986
Oct 9, 2025 25.29 26.98 24.48 25.46 25.46 9,920,867
Oct 8, 2025 20.44 26.46 20.31 24.47 24.47 17,104,954
Oct 7, 2025 20.62 20.85 19.89 20.44 20.44 3,793,504
Oct 6, 2025 21.06 21.49 20.38 20.54 20.54 4,665,589
Oct 3, 2025 20.90 20.98 19.78 19.96 19.96 5,784,075
Oct 2, 2025 19.19 20.59 18.92 20.44 20.44 7,816,326
Oct 1, 2025 17.38 19.41 17.31 18.76 18.76 6,561,586
Sep 30, 2025 16.90 17.53 16.46 17.27 17.27 4,751,926
Sep 29, 2025 16.51 16.96 16.35 16.92 16.92 4,890,756
Sep 26, 2025 16.53 16.62 15.44 16.31 16.31 6,601,932
Sep 25, 2025 17.45 17.47 16.53 16.61 16.61 6,788,488
Sep 24, 2025 17.15 18.57 17.11 17.76 17.76 7,477,708
Sep 23, 2025 17.54 17.82 16.95 17.08 17.08 5,835,746
Sep 22, 2025 15.72 17.28 14.80 17.26 17.26 8,914,781

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Intellia Therapeutics, Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NTLA, per a recent SEC DEF 14A filing. We estimate that the median employee at Intellia Therapeutics, Inc. is paid $329,586.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation